Multi-Omics Integration: Systems Biology, Latent Space Factorization & Machine Learning
Single-omics profiling provides only isolated snapshots of complex biology. By fusing orthogonal molecular layers—genomics, epigenomics, transcriptomics, proteomics, metabolomics, and microbiome ecosystems—into unified mathematical models, multi-omics integration uncovers causal regulatory mechanisms, therapeutic synthetic lethalities, and clinically actionable disease subtypes.
🌐 Module 1: Biological Foundations & Systems Biology
Holistic OmicsBiological systems operate as interconnected, multi-layered regulatory circuits. Genomic variants alter enhancer accessibility, changing transcription rates; alternative splicing modifies protein isoforms; post-translational phosphorylation activates enzymatic catalysis; and metabolic intermediates feedback to reprogram the epigenome. Relying on a single omics dimension obscures these multi-scale feedbacks.
Overcoming Transcriptional Buffering
Changes in mRNA expression do not reliably translate into functional phenotypes due to post-transcriptional buffering, microRNA inhibition, and proteasomal degradation. Integrating proteomics with RNA-seq filters out transcriptional noise and exposes truly active protein signaling.
Single-Cell Multi-Modal Co-Assays
Modern assays profile orthogonal modalities simultaneously from the exact same single cell:
• CITE-Seq / REAP-Seq: Cellular mRNA + surface protein antibody-derived tags (ADTs).
• 10x Multiome: Nuclear RNA expression + ATAC chromatin accessibility.
Host-Microbe Metabolic Axis
Microbial community metagenomes synthesize secondary metabolites (e.g. short-chain fatty acids, deconjugated bile acids, indole derivatives) that bind host G-protein coupled receptors and nuclear receptors to regulate systemic immunity and metabolism.
📐 Module 2: Mathematical Frameworks: Early, Intermediate & Late Fusion
Data Integration Taxonomy| Fusion Strategy | Mathematical Principle | Key Strengths | Primary Weaknesses | Representative Algorithms |
|---|---|---|---|---|
| Early Fusion (Concatenation) | Horizontally concatenating feature matrices [XDNA, XRNA, XProt] into a single massive matrix before ML modeling. | Simple implementation; directly compatible with standard ML (Random Forest, SVM). | Curse of dimensionality (p >> n); modalities with higher feature counts dominate the model. | Lasso/ElasticNet, XGBoost |
| Intermediate Fusion (Latent Space) | Joint matrix factorization decomposing heterogeneous matrices into shared sample factor space Z and modality-specific loadings W. | Disentangles shared vs assay-specific variance; robust to missing sample modalities. | Non-convex optimization; requires careful tuning of factor numbers and sparsity priors. | MOFA+, jNMF, mixOmics DIABLO |
| Late Fusion (Decision Level) | Training independent predictive models on each individual omic layer; combining posterior probabilities via weighted voting. | Handles different data modalities with customized loss functions. | Ignores non-linear cross-omic interactions and regulatory covariances. | Stacked Ensembles, Bayesian Model Averaging |
🖼️ Module 3: Multi-Omics Factor Analysis (MOFA+) Architecture
Scientific Diagram💻 Module 4: Computational Pipeline & Production Code
MOFA2 & mixOmics# Production R Script: Multi-Omics Factor Analysis (MOFA2) Training & Variance Decomposition
library(MOFA2)
library(ggplot2)
# 1. Prepare multi-omics views list (samples in columns, features in rows)
# Views: RNA expression (VST), Protein abundance (VSN), Metabolites (PQN)
data_views <- list(
mRNA = read.csv("rnaseq_vst_matrix.csv", row.names = 1),
Protein = read.csv("proteomics_vsn_matrix.csv", row.names = 1),
Metabolite = read.csv("metabolomics_pqn_matrix.csv", row.names = 1)
)
# 2. Create MOFA Object
mofa_obj <- create_mofa(data_views)
# 3. Configure Model & Training Options
model_opts <- get_default_model_options(mofa_obj)
model_opts$num_factors <- 10
train_opts <- get_default_training_options(mofa_obj)
train_opts$convergence_mode <- "medium"
train_opts$seed <- 42
# 4. Prepare & Train the MOFA Model
mofa_prep <- prepare_mofa(mofa_obj, model_options = model_opts, training_options = train_opts)
mofa_trained <- run_mofa(mofa_prep, outfile = "trained_multiomics_mofa.hdf5", use_basilisk = TRUE)
# 5. Variance Decomposition: Compute R2 explained per factor in each view
r2_variance <- get_variance_explained(mofa_trained)
print(r2_variance$r2_per_factor)
# 6. Correlate Latent Factors with Clinical Outcome (Survival / Drug Response)
clinical_meta <- read.csv("clinical_survival_metadata.csv")
correlate_factors_with_covariates(mofa_trained, covariates = clinical_meta)# Production R Script: mixOmics DIABLO Supervised Multi-Block sPLS-DA
library(mixOmics)
# 1. Ingest multi-omic blocks (samples in rows, features in columns)
X <- list(
RNA = t(read.csv("rnaseq_vst_matrix.csv", row.names = 1)),
Proteomics = t(read.csv("proteomics_vsn_matrix.csv", row.names = 1)),
Metabolomics = t(read.csv("metabolomics_pqn_matrix.csv", row.names = 1))
)
Y <- factor(clinical_meta$subtype)
# 2. Design Matrix specifying inter-block correlation weights (0.1 = discriminant emphasis)
design <- matrix(0.1, ncol = length(X), nrow = length(X), dimnames = list(names(X), names(X)))
diag(design) <- 0
# 3. Fit multi-block sPLS-DA model
diablo_model <- block.splsda(X = X, Y = Y, ncomp = 3, keepX = list(RNA=c(20,20,20), Proteomics=c(15,15,15), Metabolomics=c(10,10,10)), design = design)
# 4. Generate Circos Correlation Plot connecting multi-omics markers
plotCircos(diablo_model, cutoff = 0.75, line = TRUE)🏥 Module 5: Real-World Case Study
WHO CNS5 Precision GliomaCase: Multi-Omics Diagnostic Deconvolution of 2021 WHO CNS5 Adult-Type Diffuse Gliomas
Diagnostic Challenge: Histological examination alone cannot reliably distinguish between astrocytomas and oligodendrogliomas, leading to treatment misclassification. The WHO CNS5 classification mandates multi-modal molecular integration across four distinct omic tiers.
Tier 2 (Cytogenomics): Complete whole-arm 1p/19q codeletion (Definitive Oligodendroglioma marker)
Tier 3 (Epigenomics): DNA Methylation EPIC 850k array Random Forest classifier (DKFZ Glioblastoma Subtype)
Tier 4 (Metabolomics): LC-MS plasma D-2-hydroxyglutarate (D-2-HG > 12 μM confirming enzymatic activity).
Translational Outcome: Integrating these 4 tiers converted 100% of histologically ambiguous grade II/III gliomas into definitive molecular diagnoses, dictating whether patients received radiotherapy + PCV chemotherapy (oligodendrogliomas) or IDH-targeted vorasidenib therapy.
📦 Module 6: Essential Software Directory & Official Links
Verified Tool StackMOFA2
Factor AnalysisMulti-Omics Factor Analysis framework for unsupervised integration of bulk and single-cell multi-omics data.
Official MOFA2 Portal →mixOmics DIABLO
Supervised sPLS-DAMulti-block data integration and biomarker selection for multi-omics classification and circos visualizations.
mixOmics Project Portal →Seurat v5 WNN
Single-Cell MultiomeWeighted Nearest Neighbor algorithm integrating simultaneous RNA, protein (CITE-seq), and ATAC chromatin data.
Seurat WNN Tutorial →scVI-tools
Deep Generative MLProbabilistic deep learning models (TOTALVI, MultiVI) for joint single-cell RNA, surface protein, and chromatin profiling.
scVI-tools Documentation →Cytoscape
Network BiologyPremier open-source software platform for visualizing complex molecular interaction networks and multi-omics overlays.
Cytoscape Official Site →SNFtool
Similarity NetworksSimilarity Network Fusion combines patient similarity networks constructed from individual omics layers.
CRAN SNFtool Package →⚠️ Module 7: Bioinformatic Pitfalls & Quality Control Standards
Best Practices1. The Curse of Dimensionality (p >> n)
Combining 20,000 genes, 800,000 CpGs, and 6,000 proteins across 100 patient samples results in extreme feature-to-sample imbalance. Without feature pre-filtering or Bayesian sparsity priors (ARD in MOFA), models overfit trivially.
2. Cross-Validation Information Leakage
Performing multi-omics normalization, batch correction, or feature selection on the combined cohort before cross-validation leaks test sample distribution into the training set. All transformations MUST occur strictly within CV folds.
3. Unbalanced Modality Dominance
In early concatenation fusion, a layer with 50,000 features will completely overwhelm a metabolomics layer with 300 features, even if the metabolome holds superior predictive signal. Always balance block weights (e.g. in mixOmics).
📝 Module 8: Self-Assessment Exercises & Practice Datasets
Hands-on MasteryQ1: How does MOFA+ handle missing assays (e.g. patients with RNA-seq but missing proteomics)?
Answer: MOFA+ utilizes a probabilistic Bayesian framework with variational inference. Missing data entries or entire missing assay views are simply treated as unobserved latent variables. The model estimates the shared sample factor scores $Z$ using whichever modalities are available for that individual, and can subsequently reconstruct and impute the missing view using the learned factor weights $W$.
Q2: What is the core mathematical mechanism of Seurat v5 Weighted Nearest Neighbor (WNN)?
Answer: WNN calculates cell-specific modality weights based on information content and predictive power. For each cell, its local neighborhood in one modality (e.g. RNA) is used to predict its molecular profile in the second modality (e.g. surface protein ADT). If RNA neighbors reliably predict protein levels, the RNA modality receives a higher weight for that cell. The resulting composite affinity matrix combines both modalities dynamically per cell.
Q3: Why is Automatic Relevance Determination (ARD) crucial in matrix factorization?
Answer: Automatic Relevance Determination places hierarchical Gaussian shrinkage priors on the feature loading matrices $W$. During variational training, if a latent factor does not contribute to explaining variation in a particular omic view, its loadings for that entire view are shrunk to zero. This enables the model to automatically determine whether a biological factor is active across all modalities or specific to a single omic layer.